Market revenue in 2023 | USD 923.1 million |
Market revenue in 2030 | USD 1,598.2 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Anti-vegf agents |
Fastest growing segment | Gene & Cell Therapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma, Gene & Cell Therapy |
Key market players worldwide | Pfizer Inc, Alcon Inc, Novartis AG ADR, Bausch Health Companies Inc, Merck & Co Inc, Regeneron Pharmaceuticals Inc, AbbVie Inc, Bayer AG, Genentech, Nicox SA Share from reverse split, Coherus BioSciences Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.
Anti-vegf agents was the largest segment with a revenue share of 32.86% in 2023. Horizon Databook has segmented the Spain ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma, gene & cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.
The country’s supportive healthcare policies and initiatives to increase public awareness and monitor the disease rate are expected to boost the demand for ophthalmic drugs in the market. According to the Global Competitiveness 2020 Report, the World Economic Forum placed Spain as the nation with the world's best healthcare system.
The growing awareness about the early detection of glaucoma and other diseases related to eye ocular pressure, as well as the market adoption of new therapeutics, is contributing to the growth of the market in Spain.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain ophthalmic drugs market , including forecasts for subscribers. This country databook contains high-level insights into Spain ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account